Acarix Q2 2023 - Soft sales but building foundation for growth
2023-09-04 10:50:00
Redeye considers Acarix’s Q2 2023 report soft in terms of sales, but we see a strong operational newsflow, establishing a solid foundation for a sales ramp-up moving into 2024.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/